Skip to main content
. 2021 Sep 30;9(10):2068. doi: 10.3390/microorganisms9102068

Table 1.

Demographics, sample information, and variability.

Patient Characteristics (n = 43)
Age (years), median (IQR) 66 (58–70)
Sex (male), n (%) 28 (65)
Body weight (kg), median (IQR) 70 (61–87)
BMI (kg/m2), median (IQR) 25 (21–28)
APACHE II score (n = 41),
median (IQR) 18 (14–24)
n (%), < 15 11 (27)
≥15 30 (73)
Length of ICU-stay (days), median (IQR) 22 (14–37)
Number of patients who received a loading dose, n (%)
Yes 25 (58)
No 14 (33)
Unknown (transfer to other
hospital)
4 (9)
Number of patients that received a loading dose (yes/no), n (%)
Yes 18 (78)
No 5 (22)
Number of patients with at least one subtherapeutic 17 (40)
(<15 mg/L) fluconazole trough concentration, n (%)
Fluconazole Concentrations (n = 288)
Number of samples per patient, median (IQR) 7 (3–10)
Fluconazole Cmin (mg/L), median (IQR) 22.9 (14.7–35.2)
Fluconazole dose (mg/kg), median (IQR) 5.3 (4.5–7.0)
Fluconazole dose (mg), median (IQR) 400 (400–400)
Fluconazole dose (mg), n (%)
50 9 (3)
200 28 (10)
400 206 (72)
600 1 (0.35)
800 40 (14)
1000 1 (0.35)
1200 3 (1)
Administration route (PO), n (%) 28 (10)
SOFA score on day of sampling (n = 273), median (IQR) 7 (4–11)
Variability
%CV intrasubject 28.3
%CV intersubject 50.5

IQR: interquartile range; ICU: intensive care unit; PO: oral; %CV: coefficient of variation; Cmin: trough concentration.